{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:38:58Z","timestamp":1791517138712,"version":"4.3.4"},"reference-count":23,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A 35-year-old woman presented in 2022 to the Carling Adrenal Center with recurrent palpitations, anxiety, and diaphoresis, 9 years after right laparoscopic adrenalectomy at a local hospital for pheochromocytoma, diagnosed during pregnancy with placental abruption. Biochemical evaluation revealed markedly elevated 24-hour urinary and plasma fractionated metanephrines. Imaging identified extensive intra-abdominal tumor implants and a solitary liver lesion, raising suspicion for pheochromocytomatosis vs metastatic disease. Genetic testing was negative for major known pathogenic variants. Cytoreductive surgery successfully resected more than 200 tumor deposits, including a 15.5\u2005cm omental mass, without complications. Pathology confirmed pheochromocytomatosis, with the liver lesion identified as focal nodular hyperplasia. Postoperatively, symptoms resolved, biochemical markers significantly improved but remain at \u223c2.5- to 3.8 times above normal range, indicating residual microscopic disease (40 months follow-up). This case highlights the feasibility of cytoreductive surgery for extensive pheochromocytomatosis and the challenging distinction between tumor seeding and metastatic pheochromocytoma, emphasizing the need for lifelong biochemical surveillance.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf306","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:49:40Z","timestamp":1764679780000},"source":"Crossref","is-referenced-by-count":1,"title":["Massive Pheochromocytomatosis Treated With Cytoreductive Surgery"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-187X","authenticated-orcid":false,"given":"Tobias","family":"Carling","sequence":"first","affiliation":[{"name":"Carling Adrenal Center , Tampa, FL 33615 ,","place":["USA"]},{"name":"Department of Surgery, Hospital for Endocrine Surgery , Tampa, FL 33615 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Kalik","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital for Endocrine Surgery , Tampa, FL 33615 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"LaRue","sequence":"additional","affiliation":[{"name":"Carling Adrenal Center , Tampa, FL 33615 ,","place":["USA"]},{"name":"Department of Surgery, Hospital for Endocrine Surgery , Tampa, FL 33615 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"6","key":"2025122922445669400_luaf306-B1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025122922445669400_luaf306-B2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"issue":"4","key":"2025122922445669400_luaf306-B3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01657665","article-title":"Persistent and recurrent pheochromocytoma: the role of surgery","volume":"6","author":"Brennan","year":"1982","journal-title":"World J Surg"},{"issue":"2","key":"2025122922445669400_luaf306-B4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/clinem\/dgac563","article-title":"Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma","volume":"108","author":"Li","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025122922445669400_luaf306-B5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/clinem\/dgaa794","article-title":"Recurrence rate of sporadic pheochromocytomas after curative adrenalectomy: a systematic review and meta-analysis","volume":"106","author":"Holscher","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025122922445669400_luaf306-B6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-21-0797","article-title":"Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis","volume":"187","author":"Green","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025122922445669400_luaf306-B7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00104-019-01070-0","article-title":"[Pheochromocytomatosis after adrenalectomy: metastasis or cell seeding?]","volume":"91","author":"Weber","year":"2020","journal-title":"Chirurg"},{"issue":"1","key":"2025122922445669400_luaf306-B8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"4","key":"2025122922445669400_luaf306-B9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American neuroendocrine tumor society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"2","key":"2025122922445669400_luaf306-B10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"issue":"3","key":"2025122922445669400_luaf306-B11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","article-title":"Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement","volume":"20","author":"Ta\u00efeb","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"2025122922445669400_luaf306-B12","doi-asserted-by":"crossref","first-page":"e240296","DOI":"10.1530\/ERC-24-0296","article-title":"Improved and individualized approach to adrenal surgery","volume":"32","author":"Carling","year":"2025","journal-title":"Endocr Relat Cancer"},{"key":"2025122922445669400_luaf306-B13","first-page":"17-0026","article-title":"Pheochromocytomatosis associated with a novel TMEM127 mutation","volume":"2017","author":"Yu","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"2025122922445669400_luaf306-B14","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/RLU.0000000000003973","article-title":"Pheochromocytomatosis treated with peptide receptor radionuclide therapy","volume":"47","author":"Auerbach","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"2","key":"2025122922445669400_luaf306-B15","first-page":"e170","article-title":"Pheochromocytomatosis treated by radio-guided surgery","volume":"3","author":"Javid","year":"2017","journal-title":"AACE Clin Case Rep"},{"issue":"11","key":"2025122922445669400_luaf306-B16","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/clinem\/dgac471","article-title":"Targeted therapies in pheochromocytoma and paraganglioma","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025122922445669400_luaf306-B17","doi-asserted-by":"crossref","first-page":"e220375","DOI":"10.1530\/ERC-22-0375","article-title":"Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine","volume":"30","author":"Ta\u00efeb","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"2025122922445669400_luaf306-B18","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025122922445669400_luaf306-B19","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2012-4231","article-title":"Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma","volume":"98","author":"Ayala-Ramirez","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025122922445669400_luaf306-B20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/SLA.0000000000006493","article-title":"Omitting the escalating dosage of alpha-adrenergic blockade before pheochromocytoma resection: implementation of a treatment strategy in discordance with current guidelines","volume":"280","author":"Holscher","year":"2024","journal-title":"Ann Surg"},{"issue":"3","key":"2025122922445669400_luaf306-B21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ejendo\/lvae108","article-title":"PRAP study-partial versus radical adrenalectomy in hereditary pheochromocytomas","volume":"191","author":"Xu","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025122922445669400_luaf306-B22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jamcollsurg.2021.02.018","article-title":"Contemporary experience of posterior retroperitoneoscopic adrenalectomy in the US","volume":"232","author":"Chiu","year":"2021","journal-title":"J Am Coll Surg"},{"issue":"1","key":"2025122922445669400_luaf306-B23","doi-asserted-by":"crossref","first-page":"101977","DOI":"10.1016\/j.beem.2025.101977","article-title":"Systemic therapy for patients with metastatic pheochromocytoma and paraganglioma","volume":"39","author":"Fischer","year":"2025","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/1\/luaf306\/66149615\/luaf306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/1\/luaf306\/66149615\/luaf306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:45:07Z","timestamp":1767066307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf306\/8407086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf306","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,3]]},"article-number":"luaf306"}}